Seattle, WA -- (SBWIRE) -- 11/25/2019 -- Smart inhalers are the devices that are used for delivering a variety of medication through inhalation. The drugs used in the inhalers include anti-cholinergic, glucocorticoids, insulin, and beta-agonists for the treatment and prevention of respiratory diseases such as asthma and chronic obstructive pulmonary diseases.

These inhalers are termed smart inhalers, owing to the sensors attached as a clip on to the inhalers monitoring the right dose per intake and the technique used for inhaling the medication. The data acquired by the sensor is shared with the patient and healthcare professionals to track their inhaler usage. The data monitored is then shared using the Bluetooth technology to their mobile apps through a platform such as Hailie. Hailie systems is a type of sensors that is attached to the inhaler and shares the data through the operating platform for tracking their health and adherence rate.

Get more info about "Global Smart Inhalers Market Report" by requesting Sample Copy HERE: https://www.worldwidemarketreports.com/sample/285434

Smart Inhalers Market: Key Trends

The global smart inhalers market is driven by increased prevalence of people suffering from asthma and chronic obstructive pulmonary diseases, and technological advancements in the development of better smart inhaler devices and systems. Furthermore, untapped market potential in developing regions with more population and lack of healthcare amenities is expected to provide lucrative opportunities for smart inhalers market trends.

The growth of the smart inhalers market is attributed to increasing air pollution, increasing incidence of respiratory diseases such as COPD and asthma, and burden on healthcare services due to higher cases of COPD and asthma. In addition, increasing adoption of smart inhalers for proper management of COPD and asthma are further boosting the market growth.

Market Segmentation:

On the basis of product type, the global smart inhalers market has been segmented into DPI-based smart inhalers and MDI-based smart inhalers. On the basis of disease indication, the global smart inhalers market has been segmented into asthma and COPD. On the basis of distribution channel, the global smart inhalers market has been segmented into hospital pharmacies, retail pharmacies, and online pharmacies.

Regional Analysis:

Based on regional presence, the global smart inhalers market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America is the leading region for the global smart inhalers market due to better healthcare infrastructure and facilities, prevalence in the number of patient suffering from asthma and chronic obstructive pulmonary diseases, and increase in geriatric population. Emerging market such as LAMEA is expected to experience delayed growth, owing to poor infrastructure and healthcare facilities along with lack of awareness among the population.

Key Players:

AstraZeneca, Boehringer Ingelheim, Cohero Health, Glaxo Smith Kline, Novartis International , Opko Health, ResMed, Teva Pharmaceutical

Want to make an inquiry before purchasing this report and also want a discount? Click HERE: https://www.worldwidemarketreports.com/quiry/285434

THANKS FOR SPENDING YOUR VALUABLE TIME ON THIS VALUABLE PIECE OF INFORMATION!